20 August 2026 Biologics Clinical research Psoriatic Athritis Oral TYK2 inhibitor holds PsA gains to one year
23 July 2026 Clinical research DMARDS Rheumatoid Arthritis Cochrane backs Australian approach to RA evidence
25 June 2026 Biologics Clinical research Psoriatic Athritis Bimekizumab outperforms risankizumab in head-to-head PsA trial
30 April 2026 SPONSORED Biologics Psoriatic Athritis Webinars Cracking the psoriatic arthritis treatment puzzle
2 April 2026 Axial spondyloarthritis Biologics Clinical research Bimekizumab safety holds up with longer-term data
19 February 2026 Biologics Clinical research Psoriasis GLP-1/biologics combo delivers double win in PsA
